Media
Latest News
Washington, D.C.- Congresswoman Diana Harshbarger released the following statement following her visit to South Texas, where she saw firsthand the effects of President Biden’s border crisis.
Kingsport, TN- Today, Congresswoman Diana Harshbarger released the details of the 2021 Congressional Art Competition, where East Tennessee high school students (grades 9-12) can enter a competition to have their artwork displayed in the U.S. Capitol Building.
Washington, D.C.- Congresswoman Diana Harshbarger released the following statement following news from the Internal Revenue Service (IRS) on extending the tax filing deadline to May 17, 2021.
by: Slater Teague
Posted: Mar 11, 2021 / 10:06 PM EST / Updated: Mar 11, 2021 / 10:06 PM EST
Rep. Diana Harshbarger has introduced her first bill, legislation that she says could lead to lower prescription drug costs. To read the article, visit here.
by: Slater Teague
Posted: Mar 11, 2021 / 03:34 PM EST / Updated: Mar 11, 2021 / 03:34 PM EST
Rep. Diana Harshbarger voted against two Democratic efforts to expand background check requirements for firearms sales. Click here to read the full article.
Washington, D.C.- Congresswoman Diana Harshbarger released the following statement on introducing the PBM Accountability Study Act of 2021. The bill calls for a study into ways to increase transparency of pharmacy benefit managers (PBMs), which are the middlemen who negotiate payments between health insurers, pharmacies, and drug companies. They also determine which drugs are covered, at what prices, and set pharmacy networks and prescription drug reimbursement rates.
Washington, D.C.- Congresswoman Diana Harshbarger released the following statement after her votes against Democrat-led bills that infringe upon law-abiding citizens’ Second Amendment Rights: H.R. 8, the Background Checks Act, and H.R. 1446, the Enhanced Background Checks Act of 2021.
Washington, D.C.- Congresswoman Diana Harshbarger released the following statement outlining her opposition to the Democrats’ partisan $1.9 trillion stimulus bill.
by: Slater Teague
WASHINGTON (WJHL) — Neopharma’s pharmaceutical manufacturing facility in Bristol will keep its critical infrastructure designation even after the COVID-19 pandemic is over.
That’s according to Rep. Diana Harshbarger, who announced Thursday evening that the Cybersecurity and Infrastructure Security Agency (CISA) reaffirmed the facility’s status and said it will remain in place post-pandemic.
To read the full article, please visit here.






